article thumbnail

7 commercial, sales, and marketing predictions for 2023

pharmaphorum

In 2022, life sciences companies have been hard at work breaking down silos to better serve patients and healthcare professionals (HCPs). And in 2023, these investments will hopefully pay off. They’ve laid the necessary groundwork for cross-functional visibility, collaboration, and connectivity.

article thumbnail

Reducing real world data lag time for improved patient outcomes

Clarivate

In recent years, there has been an increased focus on real world evidence to advance medical science and improve patient quality of life. The Professional Society for Health Economics and Outcomes Research (ISPOR) has cited real world evidence (RWE) as the number one trend in healthcare decision making for the second year running [1].

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

It’s Time We Got the Most Out of Medical Affairs Data

PM360

Field Medical Affairs is an essential bridge between pharmaceutical clinical development and commercial delivery. Historically, the industry has left MSL-HCP interactions to exist on their own, focusing on objective metrics and key performance indicators (KPIs) to inform Medical Affairs impact. October 2023. EPG Health.

Medical 52
article thumbnail

What Tech Trends Do Life Sciences Marketers Need to Know About?

PM360

Will Big Tech’s moves within healthcare force the industry to change how it operates? Casey Cronin Life sciences marketers have a unique opportunity to connect with target audiences on an individual level and foster brand safety through AI advancement. Here are the best responses.

article thumbnail

Why R&D innovation holds the key to greater patient impact

European Pharmaceutical Review

Expanding this approach to simultaneously build capabilities and clinical trials in developing and underserved regions, like APAC and less wealthy healthcare systems in Latin America and Europe, is essential to driving more comprehensive clinical programmes and health equity. cited 2023 Apr 4]. 2019 [cited 2023 Apr 4].

article thumbnail

The (inevitable) digital transformation of Medical Affairs

Impetus Digital

Healthcare providers (HCPs), payers, and patients can now access medical information at their fingertips and they expect more from Pharma than in the past. MA and the healthcare community are increasingly embracing new ways of thinking about scientific data, tailoring this to different channels.

Medical 52
article thumbnail

Imagene Profiles Cancer Biomarkers in Real Time

Medgadget

This year it is scheduled for May 16-18, 2023 in Tel Aviv, and topics range from medical robotics, to bio-convergence, to the impact of AI on biopharma. Hundreds of Israeli life science firms will be showing off their products and technologies to attendees from all over the world.